Description
Decan P, in 10ml vial, 150mg/ml packaging, is an androgen and anabolic steroid also known as Nandrolone Phenylpropionate. It has been manufactured by Para pharma and is available all across the world through our international delivery service. The medication is used in the treatment of cancer patients as well as HIV patients. It is known to be effective in improving weakness and fatigue in older patients, fighting anemia, treating burn victims, and curing ulcers. It is also used to treat osteoporosis in postmenopausal women. With so much success in the medical field, bodybuilders see that as promising for their steroid cycle. Athletes who take DECAN P can expect to increase their gains by combining it with testosterone propionate in the background. This medication works best when it is combined with other anabolic steroids. It is intramuscularly injected; therefore, its administration requires an expertβs involvement. Individuals who have pre-existing health issues must check in with a medical specialist who can guide them on how to involve this drug in their steroid cycle.
Benefits:
Decan P has quite a lot of benefits that can aid your steroid cycle as a whole package, however, it should always be combined with other anabolic steroids. The following benefits of Decan P are listed below:
Increased strength
Fast acting half-life
Increased bone strength
Low estrogenic activity
Aids relief in joint pain
Increase protein synthesis
Heals and repairs damaged tissues
Muscular endurance and recovery.
Retains less water weight than decanoate.
Reduce the production of stress hormones.
Keep more muscle tissue by increasing nitrogen retention
Dosage:
Beginners are advised to start from 100mg per week to see how the results appear, and then gradually increase the dosage to 200mg per week. Otherwise, the standard dosage amongst result-oriented professional athletes is 300-400mg per week. Dosage for women is the same as that for men because it depends on the users and their steroid tolerance.
Reviews
There are no reviews yet.